Corteva (CTVA) Aktienübersicht
Corteva, Inc. ist im Bereich der Landwirtschaft tätig. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 1/6 |
| Künftiges Wachstum | 2/6 |
| Vergangene Leistung | 3/6 |
| Finanzielle Gesundheit | 5/6 |
| Dividenden | 2/6 |
CTVA Community Fair Values
Create NarrativeSee what 49 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
An Undervalued 3.3Moz Gold Project in Canada
Key takeaways Upside Gold is developing the Kena Gold Project, near the town of Nelson in the Kootenays region of southern British Columbia. Kena hosts a historical gold resource of 3.33 million ounces (561,000 ounces Indicated and 2.77 million ounces Inferred) across a 10,200-hectare land package.
Read full narrativeCorteva, Inc. Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | US$80.85 |
| 52-Wochen-Hoch | US$85.63 |
| 52-Wochen-Tief | US$60.54 |
| Beta | 0.68 |
| 1 Monat Veränderung | -5.39% |
| 3 Monate Veränderung | 7.74% |
| 1 Jahr Veränderung | 29.55% |
| 3 Jahre Veränderung | 40.39% |
| 5 Jahre Veränderung | 72.06% |
| Veränderung seit IPO | 225.88% |
Aktuelle Nachrichten und Updates
Recent updates
CTVA: Fair Value View Weighs Crop Protection Uncertainty And Planned SpinCo Separation
Corteva's analyst price target has increased by about $2, as analysts cite updated earnings models, a revised fair value of $86.05, a slightly adjusted discount rate, and modest changes to revenue growth, profit margin, and future P/E assumptions. Analyst Commentary Street research on Corteva has been active, with several price target revisions and a mix of ratings changes that give you both supportive and cautious signals to weigh.CTVA: Fair Value View Balances Crop Protection Risks And Upcoming SpinCo Separation
The analyst price target for Corteva has moved modestly higher to align with a fair value estimate of about $84, as analysts factor in updated earnings models, slightly adjusted revenue growth and profit margin assumptions, and recent price target changes across several firms. Analyst Commentary Recent Street research on Corteva shows a mix of higher price targets and a few rating downgrades, so you are seeing both optimism and caution reflected in the current analyst debate.CTVA: Crop Protection Uncertainty And SpinCo Separation Will Shape Future Risk Balance
The analyst price target for Corteva has been nudged higher, with a modest fair value uplift to $83.95 as analysts balance a series of recent target increases from multiple firms against more cautious views tied to softer crop protection trends. Analyst Commentary Recent research on Corteva reflects a split view, with several firms lifting price targets while others turn more cautious on near term fundamentals, especially in crop protection.CTVA: Mixed Crop Protection Outlook And New SpinCo Plan Will Shape Risk Balance
The analyst price target for Corteva edges higher to $83.33 from $82.76, as analysts factor in slightly firmer long term revenue growth and profit margins, while balancing more cautious views on crop protection trends and a modestly lower discount rate. Analyst Commentary Recent research on Corteva reflects a split view, with several firms lifting price targets while others turn more cautious on execution in crop protection.CTVA: Sector Uncertainty And New Ventures Will Shape Forward Risk Balance
Corteva's analyst fair value estimate has edged up to $82.76 from $82.05 as analysts refine their models and price targets following recent earnings updates and a broad wave of upward target revisions across the Street. Analyst Commentary Recent Street research around Corteva reflects an active debate, with several firms adjusting price targets and a mix of upgrades and downgrades around the latest earnings update.CTVA: Mixed Sector Backdrop And New Ventures Will Shape Future Prospects
Corteva's analyst fair value estimate has increased to $82.05 from $78.43 as analysts factor in slightly stronger revenue growth assumptions, a higher future P/E multiple, and a modestly lower discount rate, even as projected profit margins are trimmed. Analyst Commentary Recent Street research on Corteva is mixed, with several bullish analysts lifting price targets while a few high profile firms turn more cautious.CTVA: Seed And Crop Protection Split Will Shape Balanced Future Prospects
Narrative Update Analysts have modestly raised their price expectations for Corteva, with the updated fair value estimate moving by about US$0.48 per share. This reflects slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E, and is supported by recent target increases from several firms.CTVA: Planned Seed And Pesticide Split Will Support Future Earnings Power
Analysts lifted their blended fair value estimate for Corteva by about $0.19 to roughly $77.95 per share, reflecting updated price targets that factor in a mixed backdrop for chemicals and agriculture but continued confidence in the company’s ability to increase earnings. Analyst Commentary Recent research on Corteva reflects a mix of optimism and caution, with price targets clustered in the mid to high US$70s and one outlier in the low US$80s.Corteva: Get Your Piece Of SpinCo As A Stable Portfolio Compounder
Jan 10CTVA: Planned Seed And Pesticide Split Will Unlock Future Earnings Power
The analyst price target for Corteva has been nudged higher by approximately $0.05 to about $77.76, as analysts factor in a slightly lower discount rate and modestly improved long term growth expectations, despite broadly cautious sector commentary and recent target reductions. Analyst Commentary Street research on Corteva reflects a divided but generally constructive view, with price targets drifting lower but ratings remaining skewed toward positive as investors reassess the company’s post breakup trajectory and near term earnings backdrop.CTVA: Planned Seed And Pesticide Split Will Unlock Future Earnings Power
Our analyst price target for Corteva has been trimmed modestly in line with recent Street moves, as analysts factor in lower sector multiples and near term earnings uncertainty around the planned split, while still recognizing the company’s intact innovation engine and long term earnings growth potential. Analyst Commentary Street views on Corteva have become more bifurcated following the announced split, with valuation targets reset lower but ratings broadly supportive of the long term strategic rationale and earnings power.A Look At The Fair Value Of Corteva, Inc. (NYSE:CTVA)
Nov 26
CTVA: Upcoming Seed And Pesticide Split Will Unlock Shareholder Value
The analyst consensus price target for Corteva has been modestly reduced, slipping from approximately $77.86 to $77.71. Analysts reflect more cautious expectations for earnings growth in light of a mixed agricultural outlook and anticipated impacts from the company's planned business split.CTVA: Share Split Will Drive Shareholder Value Unlocking Amid Ongoing Business Realignment
Analysts have modestly reduced their average price target for Corteva by approximately $1.20. They cite a more cautious outlook amid challenging crop protection conditions and the company's recent announcement to split into two separate businesses.Analysts Offer Mixed Views as Corteva Eyes Split and Updates Guidance Amid Modest Valuation Shift
Analysts have modestly reduced their price target for Corteva by about $0.76 to $79.05. They cite uncertainty regarding the company’s planned split and the retention of legacy liabilities, though fundamentals and growth remain largely stable.High-Yield Seed Demand And Eco Policies Will Transform Agriculture
Corteva's analyst price target has been modestly reduced by $0.95 per share. Analysts cite continued uncertainty around the planned corporate split and complex crop protection market dynamics.High-Yield Seed Demand And Eco Policies Will Transform Agriculture
Analysts maintained their price target for Corteva at $80.76, citing margin expansion and EBITDA growth driven by successful innovation, favorable market fundamentals, and strong execution. Analyst Commentary Ongoing cost reductions, successful innovation, and strong execution are driving margin expansion and double-digit EBITDA growth.Corteva's (NYSE:CTVA) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 26Corteva's (NYSE:CTVA) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 01Investors Interested In Corteva, Inc.'s (NYSE:CTVA) Earnings
Jul 28We Think Corteva (NYSE:CTVA) Can Stay On Top Of Its Debt
Jul 14Estimating The Intrinsic Value Of Corteva, Inc. (NYSE:CTVA)
May 06Corteva: Upgraded To Strong Buy On Tariffs, Currency Tailwinds, Strong Guidance
Apr 21Pure Market Inefficiency In Corteva Preferreds Pricings
Mar 30CTA.PR.B: An Undervalued Investment-Grade Opportunity From Corteva
Feb 09Corteva: A Wide-Moat Play On Commodity Prices
Jan 10Corteva Q3: Lower Commodity And Raw Material Costs Ahead, Potential Margin Expansion
Nov 10Aktionärsrenditen
| CTVA | US Chemicals | US Markt | |
|---|---|---|---|
| 7D | 1.8% | -0.7% | 0.9% |
| 1Y | 29.5% | 12.4% | 28.2% |
Rendite im Vergleich zur Industrie: CTVA übertraf die Branche US Chemicals , die im vergangenen Jahr eine Rendite von 12.4 erzielte.
Rendite vs. Markt: CTVA übertraf den Markt US, der im vergangenen Jahr eine Rendite von 28.2 erzielte.
Preisvolatilität
| CTVA volatility | |
|---|---|
| CTVA Average Weekly Movement | 3.1% |
| Chemicals Industry Average Movement | 7.4% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.2% |
Stabiler Aktienkurs: CTVA hatte in den letzten 3 Monaten im Vergleich zum US -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: CTVADie wöchentliche Volatilität (3%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1802 | 21,500 | Chuck Magro | www.corteva.com |
Corteva, Inc. ist im Bereich der Landwirtschaft tätig. Das Unternehmen ist in zwei Segmenten tätig: Saatgut und Pflanzenschutz. Das Segment Saatgut entwickelt und liefert fortschrittliches Keimplasma und Traits, die optimale Erträge für landwirtschaftliche Betriebe liefern.
Corteva, Inc.'s Grundlagenzusammenfassung
| CTVA grundlegende Statistiken | |
|---|---|
| Marktanteil | US$54.28b |
| Gewinn(TTM) | US$1.19b |
| Umsatz(TTM) | US$17.40b |
Ist CTVA zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| CTVA Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | US$17.40b |
| Kosten der Einnahmen | US$9.17b |
| Bruttogewinn | US$8.23b |
| Sonstige Ausgaben | US$7.04b |
| Gewinn | US$1.19b |
Zuletzt gemeldete Gewinne
Dec 31, 2025
Datum des nächsten Gewinnberichts
May 05, 2026
| Gewinn per Aktie (EPS) | 1.78 |
| Bruttomarge | 47.29% |
| Nettogewinnspanne | 6.86% |
| Schulden/Eigenkapital-Verhältnis | 10.6% |
Wie hat sich CTVA auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
Zahlt CTVA eine zuverlässige Dividende?
Siehe CTVA Dividendenhistorie und Benchmarks| Corteva Dividendentermine | |
|---|---|
| Ex-Dividenden Datum | Jun 01 2026 |
| Datum der Dividendenzahlung | Jun 15 2026 |
| Tage bis Ex-Dividende | 27 days |
| Tage bis zum Datum der Dividendenzahlung | 41 days |
Zahlt CTVA eine zuverlässige Dividende?
Siehe CTVA Dividendenhistorie und BenchmarksUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/04 19:42 |
| Aktienkurs zum Tagesende | 2026/05/01 00:00 |
| Gewinne | 2025/12/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Corteva, Inc. wird von 39 Analysten beobachtet. 19 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| null null | Argus Research Company |
| Benjamin Theurer | Barclays |
| Benjamin Theurer | Barclays |